SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,347.82 -505.08
( -0.68%)

Global Indices

Nasdaq

52,511.77 524.74
(1.01%)

Dow Jones

7,731.20 19.47
(0.25%)

Hang Seng

64,728.80 653.38
(1.02%)

Nikkei 225

10,731.75 -32.94
(-0.31%)

Forex

USD-INR

94.90 0.12
(0.13%)

EUR-INR

106.44 -0.03
(-0.02%)

GBP-INR

126.38 0.12
(0.10%)

JPY-INR

0.60 0.00
(-0.04%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Industry :

BSE Code

ISIN Demat

Book Value()

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

EPS(TTM)

Face Value()

Div & Yield %

Back

Alembic Pharmaceuticals consolidated net profit rises 12.11% in the June 2026 quarter

Aug 04,2026

Net profit of Alembic Pharmaceuticals rose 12.11% to Rs 173.07 crore in the quarter ended June 2026 as against Rs 154.38 crore during the previous quarter ended June 2025. Sales rose 25.66% to Rs 2149.77 crore in the quarter ended June 2026 as against Rs 1710.72 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	2149.77	1710.72	26
OPM %	15.44	16.42	-
PBDT	319.57	263.88	21
PBT	221.86	190.11	17
NP	173.07	154.38	12

73,347.82 -505.08 ( -0.68%)

52,511.77 524.74 (1.01%)

7,731.20 19.47 (0.25%)

64,728.80 653.38 (1.02%)

10,731.75 -32.94 (-0.31%)

94.90 0.12 (0.13%)

106.44 -0.03 (-0.02%)

126.38 0.12 (0.10%)

0.60 0.00 (-0.04%)